Social media video surfaced Wednesday allegedly showing a warehouse in Syria stacked with captagon, an illicit drug that had transformed the
Dictators sometimes resort to manufacturing and trafficking drugs to raise money for their shoddy régimes. Trump's bro Kim Jong-un famously sells illicit drugs. North Korean diplomats are often drug pushers in countries where North Korea has embassies.
So when a warehouse linked to the ousted al-Assad régime in Syria was found to be stocked with the drug captagon, it simply confirmed suspicions about Syria's involvement in the drug trade.
A social media video surfaced Wednesday allegedly showing a warehouse in Syria stacked with captagon, an illicit drug that had transformed the country into a narco-state under former President Bashar al-Assad’s rule. The large warehouse was reportedly located at the headquarters of a military division near Damascus that was commanded by Assad’s brother Maher. CNN is unable immediately to verify the location. A voice commenting over the video says that it is “one of the largest warehouse facilities of captagon manufacturing of pills.” Piles of pills are seen on the floor along with drug-making equipment. If confirmed, the discovery would support claims by the United States and others that the Assad regime had been involved in actively exporting the drug. Captagon has become a significant social problem in neighboring Arab nations and spurred some of them to engage in talks with the former Syrian regime to curb its trafficking. It is a highly addictive drug, mostly containing amphetamine, that is sometimes described as the “poor man’s cocaine.” Studies over recent years have estimated the annual trade in the drug to be worth billions of dollars. It is believed to have become an economic lifeline for the Assad regime while it was under crippling American sanctions. This week, Saudi-owned Al Arabiya reported the discovery of thousands of captagon pills at the Mazzeh airbase south of Damascus.
This was a bigtime operation, not just a couple of bros in a basement with a chemistry set.
Tulsi Gabbard, Trump's nominee for director of national intelligence, is a longtime apologist for drug kingpin Bashar al-Assad.
Before she was redpilled, Gabbard’s outstanding trait was warmth toward dictators. In 2017, she traveled to Syria and met with Assad not once but twice, explaining that she met the dictator because “the suffering of the Syrian people . . . has been weighing heavily on my heart.” Like so many political pilgrims, Gabbard saw what she wanted to see, not the reality staring her in the face. In 2017, she had every reason to know that Assad had not only used chemical weapons against the Syrian people, but had welcomed Russian assistance in his civil war, and that Iranian-allied troops and Russian fighters had conducted operations against American interests in the region. No one knows what Assad and Gabbard discussed in their two hours together, but soon after she emerged, Gabbard was expressing skepticism that Assad had really used poison gas, and by the time of her 2020 presidential run, she was citing full-on conspiracy sites that claimed the chemical attacks were false-flag operations designed to bring the United States into the war. Gabbard’s credulousness—if that’s what it is—looks particularly obscene this week, as stories are coming out about the grotesque human rights abuses committed by Assad in Sednaya prison and at other places around Syria. [ ... ] Gabbard demonstrated similar credulousness about Russia and Putin, mouthing so many Kremlin talking points that RT hosts referred to her as “Russia’s girlfriend.”
Of course Russia has been al-Assad's main backer for the past decade. The al-Assad family escaped to Moscow before Syrian rebel forces could apprehend them.
Gabbard may be considered "Russia's girlfriend" by Russian state TV, but she's more generally a harlot for despots.
Trump wants to send the US Army into Mexico to destroy alleged fentanyl labs. But he's quite willing to kiss the butts of dictators who are producing and exporting drugs.
